Eris Lifesciences Limited (NSE:ERIS)
India · Delayed Price · Currency is INR 1,451.40
+61.30 (4.41%)
Apr 15, 2026, 3:29 PM IST
Eris Lifesciences Market Cap
Eris Lifesciences has a market cap or net worth of 192.59 billion as of April 15, 2026. Its market cap has increased by 3.47% in one year.
Market Cap
192.59B
Enterprise Value
219.85B
Revenue
30.65B
Ranking
n/a
PE Ratio
43.95
Stock Price
1,451.40
Market Cap Chart
Since June 29, 2017, Eris Lifesciences's market cap has increased from 82.71B to 192.59B, an increase of 132.86%. That is a compound annual growth rate of 10.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 192.59B | -6.09% |
| Dec 31, 2025 | 205.09B | 9.67% |
| Dec 31, 2024 | 187.00B | 51.07% |
| Dec 29, 2023 | 123.79B | 40.63% |
| Dec 30, 2022 | 88.02B | -14.80% |
| Dec 31, 2021 | 103.31B | 31.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Jun 29, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Ipca Laboratories | 368.12B |
| Ajanta Pharma | 361.84B |
| Emcure Pharmaceuticals | 309.11B |
| Gland Pharma | 284.09B |
| Wockhardt | 221.51B |
| Piramal Pharma | 194.49B |
| NATCO Pharma | 192.95B |
| Alembic Pharmaceuticals | 141.03B |